Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

A Mindfulness-based Intervention for the Improvement of Treatment-Related Symptoms in Patients with Hematologic Cancer

Trial Status: closed to accrual

This clinical trial evaluates a mindfulness-based therapy for insomnia (MBTI+) intervention for the improvement of treatment-related symptoms like insomnia, pain, and distress in patients who received treatment for a blood (hematologic) cancer. Patients who receive treatment for a hematologic cancer are often left with side effects like sleep disturbances, fatigue, pain, and distress. The MBTI+ intervention uses sleep restriction and stimulus control with mindfulness principles and exercises like meditation to reduce these treatment-related symptoms. This clinical trial refines and tests the MBTI+ intervention for the reduction of treatment-related symptoms in patients with hematologic cancers.